Old Web
English
Sign In
Acemap
>
authorDetail
>
Natalie D. Keirstead
Natalie D. Keirstead
Merck & Co.
Medical physics
regulatory policy
Anatomy
Clinical study design
Anatomical pathology
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Scientific and Regulatory Policy Committee Points to Consider: Biological Sample Retention From Nonclinical Toxicity Studies.
2021
Toxicologic Pathology
Carole E. Harbison
Adam D. Aulbach
Bindu Bennet
Molly H. Boyle
Mary Carsillo
Torrie A. Crabbs
Natalie D. Keirstead
Krista M. D. La Perle
Arun R. Pandiri
Ahmed M. Shoieb
William Siska
Show All
Source
Cite
Save
Citations (0)
Scientific and Regulatory Policy Committee Points to Consider*: Review of Scientific and Regulatory Policy Committee Points to Consider: Review of Current Practices for Ultrastructural Pathology Evaluations in Support of Nonclinical Toxicology Studies:
2019
Toxicologic Pathology
Natalie D. Keirstead
Evan B. Janovitz
James T. Meehan
Bruce E. LeRoy
John R. Megill
Richard A. Peterson
Regis Masson
Heike A. Marxfeld
Show All
Source
Cite
Save
Citations (0)
1